Health Care Industries In Which We Invest
- Biopharmaceutical Supply Chain Services and Products
- Health Care Services
- Health Care Information Technology Enabled Services
- Medical Devices and Diagnostics
Our Geographic Focus
Great Point Partners invests primarily in companies located in the United States, Canada and Western Europe.
- Exited Investment
- Greenville, SC
- Clinical Trial Site Network
- Current Investment
- Raleigh, NC
- Biopharmaceutical Contract Manufacturing
- Current Investment
- Houston, TX
- Outsourced Surgical Assistants
- Current Investment
- Houston, TX
- Contract Manufacturer of Medical Devices
- Current Investment
- San Antonio, TX
- Operator of Pediatric Urgent Care Clinics
- Current Investment
- Hudson, OH
- Outsourced Radiology Services
- Exited Investment
- Jacksonville, FL
- Technology-enabled population health management
- Exited Investment
- Malvern, PA
- Clinical Trial Supplies Management
- Current Investment
- Southborough, MA
- Nationwide Provider of Post Approval Drug Registries
- Exited Investment
- Long Crendon, UK
- Temperature Controlled Packaging for Pharmaceuticals
- Exited Investment
- Ireland
- Contract Manufacturing of Medical Devices
- Current Investment
- Phoenix, AZ
- Medical Claims Flow Management
- Current Investment
- Flagstaff, AZ
- Virtual Speech Therapy and Mental Health Services
- Exited Investment
- Glendale, CA
- Autism Services
- Exited Investment
- Fremont, CA
- Biopharmaceutical Contract Manufacturing
- Current Investment
- Spokane, WA
- Provider of Home Care Services
- Current Investment
- San Diego, CA
- Physical Therapy Provider
- Current Investment
- San Diego, CA
- Cell and Gene Therapy Contract Manufacturing
- Current Investment
- San Diego, CA
- Services for biotechnology companies
- Exited Investment
- Ann Arbor, MI
- Intra-operative Neurophysiological Monitoring
- Exited Investment
- Montréal, Quebec
- Biomarker Discovery Services
- Exited Investment
- Brookfield, WI
- Sales Automation & Exchange Technology
- Current Investment
- Toronto, Canada
- Clinical Trial Software
and Services 
- Exited Investment
- Oklahoma City, OK
- Biopharmaceutical Contract Manufacturing
- Exited Investment
- Indianapolis, IN
- Outsourced Medical Cost Management
- Exited Investment
- Manassas, VA
- Cell Culture Media
- Current Investment
- Washington, D.C.
- Healthcare Communications & Marketing
- Exited Investment
- Whitestone, NY
- Orthopedic and Sports Physical Therapy
- Current Investment
- Iselin, New Jersey
- Biometrics Contract Research Organization
- Exited Investment
- Charleroi, Belgium
- Cell and Gene Therapy Contract Manufacturing
- Current Investment
- Mönchengladbach, Germany
- Central and Specialty Lab
- Great Point Partners invests primarily in companies located in the United States, Canada and Western Europe.
Investment Size
We target companies that are generating between $10-100 million of revenue and $2-12 million of EBITDA. Our equity investments range from $7-$50 million.
Tuck-in Acquisitions
Great Point Partners actively sources tuck-in acquisition opportunities for our portfolio companies and have completed over 75 tuck-in acquisitions since our first investment in 2006. Tuck-in candidates generate over $1 million of revenue and are profitable. We like to invest in companies where tuck-in acquisitions can augment organic growth.
Minority vs. Majority
We are equally comfortable with minority and majority ownership investments. In fact, about 25% of our investments are minority interests.
Investment Flexibility
We offer a wide range of shareholder liquidity and ownership options – seeking to align interests between management teams and Great Point Partners. Generally, we are the first institutional investor, and always the lead investor. We structure investments that sustain long-term growth, support financial stability, and maximize shareholder value.